Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 3271 AL 3285

B cell depletion therapy for new-onset opsoclonus-myoclonus

Pranzatelli MR, Tate ED, Swan JA, Travelstead AL, Colliver JA, Verhulst SJ, Crosley CJ, Graf WD, Joseph SA, Kelfer HM, Raju GP.

Mov Disord. 2010 Jan 30;25(2):238-42. doi: 10.1002/mds.22941.

Fragile X-associated tremor/ataxia syndrome (FXTAS) with myoclonus

Poston KL, McGovern RA, Goldman JS, Caccappolo E, Mazzoni P.

Mov Disord. 2010 Mar 15;25(4):514-6. doi: 10.1002/mds.22929.

Opsoclonus-myoclonus in children associated or not with neuroblastoma

Krug P, Schleiermacher G, Michon J, Valteau-Couanet D, Brisse H, Peuchmaur M, Sarnacki S, Martelli H, Desguerre I, Tardieu M.

Eur J Paediatr Neurol. 2010 Sep;14(5):400-9. doi: 10.1016/j.ejpn.2009.12.005. Epub 2010 Jan 27.

A distinct phenotype of leg hyperreflexia in a Japanese family with Gerstmann-Sträussler-Scheinker syndrome (P102L)

Takazawa T, Ikeda K, Ito H, Aoyagi J, Nakamura Y, Miura K, Iwamoto K, Kano O, Kawabe K, Iwasaki Y.

Intern Med. 2010;49(4):339-42. doi: 10.2169/internalmedicine.49.2864. Epub 2010 Feb 15.

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist

Atack JR, Hallett DJ, Tye S, Wafford KA, Ryan C, Sanabria-Bohórquez SM, Eng WS, Gibson RE, Burns HD, Dawson GR, Carling RW, Street LJ, Pike A, De Lepeleire I, Van Laere K, Bormans G, de Hoon JN, Van Hecken A, McKernan RM, Murphy MG, Hargreaves RJ.

J Psychopharmacol. 2011 Mar;25(3):329-44. doi: 10.1177/0269881109354928. Epub 2010 Feb 15.

[A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody]

Kobayakawa Y, Tateishi T, Kawamura N, Doi H, Ohyagi Y, Kira J.

Rinsho Shinkeigaku. 2010 Feb;50(2):92-7. doi: 10.5692/clinicalneurol.50.92.

Dementia with Lewy bodies associated with ataxia, myoclonus, and cortical blindness

Hindle JV, Bridges L, Chohan G.

Mov Disord. 2010 Jul 15;25(9):1301-2. doi: 10.1002/mds.23074.

Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome

Wu SB, Ma YS, Wu YT, Chen YC, Wei YH.

Mol Neurobiol. 2010 Jun;41(2-3):256-66. doi: 10.1007/s12035-010-8123-7. Epub 2010 Apr 23.

[Paraneoplastic opsoclonus-myoclonus syndrome--a review]

Matsumoto H, Ugawa Y.

Brain Nerve. 2010 Apr;62(4):365-9.

HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases

Kanjanasut N, Phanthumchinda K, Bhidayasiri R.

Clin Neurol Neurosurg. 2010 Sep;112(7):572-4. doi: 10.1016/j.clineuro.2010.03.024. Epub 2010 Apr 27.

Neuropsychological decline/improvement in opsoclonus myoclonus ataxia

Smith ML, Thawani N, Johnstone B, Stucky R.

Neurocase. 2010 Aug;16(4):352-7. doi: 10.1080/13554791003620264. Epub 2010 May 5.

Opsoclonus-myoclonus syndrome attributable to hepatitis C infection

Ertekin V, Tan H.

Pediatr Neurol. 2010 Jun;42(6):441-2. doi: 10.1016/j.pediatrneurol.2010.02.009.

[Prion disease--the characteristics and diagnostic points in Japan]

Sanjo N, Mizusawa H.

Rinsho Shinkeigaku. 2010 May;50(5):287-300. doi: 10.5692/clinicalneurol.50.287.

Recurrent acute obstructive hydrocephalus as clinical onset of cerebral Whipple's disease

Seneca V, Imperato A, Colella G, Cioffi V, Mariniello G, Gangemi M.

Clin Neurol Neurosurg. 2010 Oct;112(8):717-21. doi: 10.1016/j.clineuro.2010.04.021.

Carisoprodol withdrawal after internet purchase

Eleid MF, Krahn LE, Agrwal N, Goodman BP.

Neurologist. 2010 Jul;16(4):262-4. doi: 10.1097/NRL.0b013e3181aa917e.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias